Prior studies by Kenny et al. showed that of the six patients with breast cancer who were treated with the TS inhibitor capecitabine, the 18F-FLT uptake kinetics increased at 1 h after treatment [15]. The gene discussed is TYMS; the disease is breast carcinoma.